Sales decline 11.52% to Rs 25.20 crore
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 1.89 crore in the quarter ended December 2020 as against net loss of Rs 2.35 crore during the previous quarter ended December 2019. Sales declined 11.52% to Rs 25.20 crore in the quarter ended December 2020 as against Rs 28.48 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales25.2028.48 -12 OPM %-8.97-7.06 -PBDT-2.36-3.14 25 PBT-2.42-3.20 24 NP-1.89-2.35 20Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content